Risk of Thromboembolic Events with IVIg Administration Evaluated
Administration of intravenous immune globulin (IVIg) to prevent infection may contribute to the risk of thromboembolic events.
Administration of intravenous immune globulin (IVIg) to prevent infection may contribute to the risk of thromboembolic events.
Routine imaging in patients with diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is not recommended.
Genome-wide association-studies (GWAS) can be used to establish allele mismatch in acute-graft-versus-host disease (aGVHD).
Triple negative cases of thrombocytopenia and meylofibrosis not associated with a homogenous disease entity.
CXCR4 signaling genes can serve as potential markers to predict survival and progression to metastasis in Ewing sarcoma.
Physicians have varying perceptions on the impact of seeking philanthropy from grateful patients.
Renal mass biopsies can be conducted with accuracy in patients with small renal masses (<4 cm).
Ibrutinib is a well-tolerated therapy in patients with chronic lymphocytic leukemia (CLL) that may increase IgA levels and decrease infection rate.
Platinum combination with pemetrexed resulted in better disease control and improved survival in patients with non-small cell lung cancer.